Table 2.
Summary of studies from developing countries.
Louis et al. (6) | Nathan et al. (9) | Bertrand et al. (10) | |
---|---|---|---|
Number of patients | 55 | 70 | 35 |
Invasive/NIV | 39/16 | 10/60 | 26/9 |
Underlying disease | |||
NMD | 33 (60%) | 7 (10%) | 12 (34%) |
Primary respiratory diseases | – | 40 (57%) | 17 (48%) |
CCHS | 5 (9%) | – | 2 (6%) |
Age at initiation of HMV (median in years) | 3.5 | 0.9 | 1 |
Duration of HMV (median in months) | 42.5 | 12 | 21 |
Overnight ventilation | 18 (33%)* | 38 (54%) | N/A |
Ventilation 24 h a day | 26 (47%) | 32 (46%) | N/A |
Died | 21 (38%) | 10 (14%) | 6 (17%) |
Information lacking for 11 patients.
NIV, non-invasive ventilation; NMD, neuromuscular disease; CCHS, congenital central hypoventilation syndrome; HMV, mechanical ventilation at home.